Brought to you by 
Navam Capital provides $1mm in seed funding to dermatology start-up Vyome
27 Aug 2014
Executive Summary
Navam Capital provided $1mm in seed financing to Vyome Biosciences Pvt. Ltd., which was founded two months ago by Harvard Medical School and Institute of Genomics and Integrative Biology scientists to develop drug candidates for skin fungal infections, skin pigmentation disorders, and chronic wound healing.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
-
Drug Delivery
- Topical Delivery
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Navam Capital provides $1mm in seed funding to dermatology start-up Vyome
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice